CoppoR.Non-steroidal and non cytotoxic therapies for nephritic syndrome.Nephrol Dial Transplant2008; 23(6): 1793–96.
2.
BergA.L., Nilsson-EhleP., ArnadottirM.Benefical effects of ACTH on serum lipoprotein profile and glomerular function in patients with membranous nephropathy.Kidney Int1999; 56: 1534–43.
3.
BergA.L., and ArnadottirM.ACTH-induced improvement in nephritic syndrome in patients with a variety of diagnoses.Nephrol Dial Transplant2004; 19: 1305–07.
4.
RauenT., MichealisA., FleogeJ., MertensP.R.Case series of idiopathic membranous nephropathy with long-term beneficial effects of ACTH peptide 1–24.Clin Nephrol2009; 71(6): 637–42.
5.
PonticelliC., PasseriniP., SalvadoriM.. A Randomized Pilot Trial Comparing Methylprednisolone Plus a Cytotoxic Agent Versus Synthetic Adrenocorticotropic Hormone in Idiopatic Membranous Nephropathy.Am J Kid Dis2006; 47(2): 233–40.
6.
JolesJ.A., KunterU., JanssenU.. Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats.J Am Soc Nephrol2000; 11(4): 669–83.
7.
AttiaD.M., NiZ.N., BoerP.. Proteinuria is preceded by decreased nitric oxide synthesis and prevented by a NO donor in cholesterol-fed rats.Kidney Int2002; 61: 1776–87.
8.
AttiaD.M., FeronO., GoldschmedingR.. Hypercholesterolemia in rats induces podocytes stress and decreases renal cortical nitric oxide synthesis via an angiotensin II type receptor-sensitive mechanism.J Am Soc Nephrol2004; 15(4): 949–57.
9.
KeaneW.F.Effect of lipids on glomerular injury and progression of renal disease.Verh K Acad Geneeskd Belg1994; 56(2): 91–104.
10.
LorussoP., CipolliniI., BottaiA., BarsottiG.Effetto dell'ACTH sulla proteinuria nelle glomerulonefriti.Giornale Italiano di Nefrologia2009; 26: S47, Settembre-Ottobre 2009, S32, Abstract.
11.
AbeyagunawardenaA.S., HindmarshP., TrompeterR.S.Adenocortical suppression increases the risk of relapse in nephritic syndrome.Arc Dis Child2007; 92(7): 585–8.